CorDynamics Presents New HFpEF Research at the AHA Basic Cardiovascular Sciences Scientific SessionsJuly 13, 2026 | Scientific Meetings
CorDynamics is pleased to present new research at the American Heart Association (AHA) Basic Cardiovascular Sciences (BCVS) Scientific Sessions, highlighting the application of advanced cardiovascular imaging techniques to improve the assessment of heart failure with preserved ejection fraction (HFpEF).
The research demonstrates how dobutamine stress echocardiography combined with speckle-tracking echocardiography (STE) can identify impaired diastolic reserve that is not fully apparent under resting conditions. By moving beyond conventional resting echocardiography, stress imaging provides a more sensitive assessment of cardiac function and can reveal subtle abnormalities that may otherwise go undetected.
HFpEF remains one of the most challenging areas in cardiovascular drug development. As new therapies continue to emerge, there is an increasing need for translational preclinical endpoints capable of detecting meaningful functional changes early in disease progression.
This work reflects CorDynamics’ ongoing investment in advanced cardiovascular phenotyping technologies that help sponsors generate high-quality, decision-enabling data. Our integrated cardiovascular research platform combines advanced imaging with invasive hemodynamics, pressure-volume loop analysis, telemetry, electrophysiology, pathology, and biomarker assessment to provide comprehensive evaluations of therapeutic efficacy across a broad range of cardiovascular disease areas.CorDynamics remains committed to advancing translational cardiovascular research by developing and applying innovative preclinical endpoints that help bridge the gap between discovery and the clinic.
To learn more about CorDynamics’ cardiovascular efficacy and translational pharmacology capabilities, please visit www.cordynamics.com or contact our scientific team.
